Anti-HYAS2/ HAS2 monoclonal antibody

Anti-HYAS2/ HAS2 antibody for FACS & in-vivo assay

Target products collectionGo to HAS2/HAS2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0570-Ab-1/ GM-Tg-hg-MP0570-Ab-2Anti-Human HAS2 monoclonal antibodyHuman
GM-Tg-rg-MP0570-Ab-1/ GM-Tg-rg-MP0570-Ab-2Anti-Rat HAS2 monoclonal antibodyRat
GM-Tg-mg-MP0570-Ab-1/ GM-Tg-mg-MP0570-Ab-2Anti-Mouse HAS2 monoclonal antibodyMouse
GM-Tg-cynog-MP0570-Ab-1/ GM-Tg-cynog-MP0570-Ab-2Anti-Cynomolgus/ Rhesus macaque HAS2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0570-Ab-1/ GM-Tg-felg-MP0570-Ab-2Anti-Feline HAS2 monoclonal antibodyFeline
GM-Tg-cang-MP0570-Ab-1/ GM-Tg-cang-MP0570-Ab-2Anti-Canine HAS2 monoclonal antibodyCanine
GM-Tg-bovg-MP0570-Ab-1/ GM-Tg-bovg-MP0570-Ab-2Anti-Bovine HAS2 monoclonal antibodyBovine
GM-Tg-equg-MP0570-Ab-1/ GM-Tg-equg-MP0570-Ab-2Anti-Equine HAS2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0570-Ab-1/ GM-Tg-hg-MP0570-Ab-2; GM-Tg-rg-MP0570-Ab-1/ GM-Tg-rg-MP0570-Ab-2;
GM-Tg-mg-MP0570-Ab-1/ GM-Tg-mg-MP0570-Ab-2; GM-Tg-cynog-MP0570-Ab-1/ GM-Tg-cynog-MP0570-Ab-2;
GM-Tg-felg-MP0570-Ab-1/ GM-Tg-felg-MP0570-Ab-2; GM-Tg-cang-MP0570-Ab-1/ GM-Tg-cang-MP0570-Ab-2;
GM-Tg-bovg-MP0570-Ab-1/ GM-Tg-bovg-MP0570-Ab-2; GM-Tg-equg-MP0570-Ab-1/ GM-Tg-equg-MP0570-Ab-2
Products NameAnti-HAS2 monoclonal antibody
Formatmab
Target NameHAS2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-HAS2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species HYAS2/ HAS2 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0570
    Target NameHAS2
    Gene ID3037,15117,25694,703353,482032,101099432,281220,100009708
    Gene Symbol and SynonymsHAS2
    Uniprot AccessionQ92819,O35776,O97711
    Uniprot Entry NameHYAS2_HUMAN,HYAS2_RAT,HYAS2_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000170961
    Target ClassificationN/A

    The target: HAS2, gene name: HAS2, also named as . Hyaluronan or hyaluronic acid (HA) is a high molecular weight unbranched polysaccharide synthesized by a wide variety of organisms from bacteria to mammals, and is a constituent of the extracellular matrix.  It consists of alternating glucuronic acid and N-acetylglucosamine residues that are linked by beta-1-3 and beta-1-4 glycosidic bonds.  HA is synthesized by membrane-bound synthase at the inner surface of the plasma membrane, and the chains are extruded through pore-like structures into the extracellular space.  It serves a variety of functions, including space filling, lubrication of joints, and provision of a matrix through which cells can migrate.  HA is actively produced during wound healing and tissue repair to provide a framework for ingrowth of blood vessels and fibroblasts.  Changes in the serum concentration of HA are associated with inflammatory and degenerative arthropathies such as rheumatoid arthritis.  In addition, the interaction of HA with the leukocyte receptor CD44 is important in tissue-specific homing by leukocytes, and overexpression of HA receptors has been correlated with tumor metastasis.  HAS2 is a member of the newly identified vertebrate gene family encoding putative hyaluronan synthases, and its amino acid sequence shows significant homology to glycosaminoglycan synthetase (DG42) from Xenopus laevis, and human and murine hyaluronan synthase 1. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.